Newron Pharmaceuticals Management
Management criteria checks 3/4
Newron Pharmaceuticals' CEO is Stefan Weber, appointed in Jun 2012, has a tenure of 11.83 years. total yearly compensation is €510.00K, comprised of 93.1% salary and 6.9% bonuses, including company stock and options. directly owns 0.11% of the company’s shares, worth CHF136.15K. The average tenure of the management team and the board of directors is 11.8 years and 12.3 years respectively.
Key information
Stefan Weber
Chief executive officer
€510.0k
Total compensation
| CEO salary percentage | 93.1% |
| CEO tenure | 11.8yrs |
| CEO ownership | 0.1% |
| Management average tenure | 11.8yrs |
| Board average tenure | 12.3yrs |
Recent management updates
Recent updates
Here's Why We Think Newron Pharmaceuticals S.p.A.'s (VTX:NWRN) CEO Compensation Looks Fair for the time being
Apr 11
We Think Newron Pharmaceuticals (VTX:NWRN) Has A Fair Chunk Of Debt
Nov 06Shareholders May Be Wary Of Increasing Newron Pharmaceuticals S.p.A.'s (VTX:NWRN) CEO Compensation Package
Apr 06Newron Pharmaceuticals (VTX:NWRN) Has Debt But No Earnings; Should You Worry?
Apr 01A Look At Newron Pharmaceuticals' (VTX:NWRN) Share Price Returns
Feb 25CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | €510k | €475k | -€16m |
| Sep 30 2023 | n/a | n/a | -€16m |
| Jun 30 2023 | n/a | n/a | -€16m |
| Mar 31 2023 | n/a | n/a | -€17m |
| Dec 31 2022 | €498k | €429k | -€17m |
| Sep 30 2022 | n/a | n/a | -€16m |
| Jun 30 2022 | n/a | n/a | -€14m |
| Mar 31 2022 | n/a | n/a | -€15m |
| Dec 31 2021 | €510k | €414k | -€15m |
| Sep 30 2021 | n/a | n/a | -€17m |
| Jun 30 2021 | n/a | n/a | -€20m |
| Mar 31 2021 | n/a | n/a | -€20m |
| Dec 31 2020 | €582k | €403k | -€21m |
| Sep 30 2020 | n/a | n/a | -€19m |
| Jun 30 2020 | n/a | n/a | -€17m |
| Mar 31 2020 | n/a | n/a | -€18m |
| Dec 31 2019 | €691k | €440k | -€20m |
| Sep 30 2019 | n/a | n/a | -€21m |
| Jun 30 2019 | n/a | n/a | -€21m |
| Mar 31 2019 | n/a | n/a | -€18m |
| Dec 31 2018 | €647k | €430k | -€15m |
| Sep 30 2018 | n/a | n/a | -€15m |
| Jun 30 2018 | n/a | n/a | -€14m |
| Mar 31 2018 | n/a | n/a | -€10m |
| Dec 31 2017 | €563k | €418k | -€5m |
Compensation vs Market: Stefan's total compensation ($USD547.09K) is about average for companies of similar size in the Swiss market ($USD586.02K).
Compensation vs Earnings: Stefan's compensation has increased whilst the company is unprofitable.
CEO
Stefan Weber (58 yo)
11.8yrs
Tenure
€510,000
Compensation
Mr. Stefan Weber serves as the Chief Financial Officer and Finances and Administration Director at Duktus S.A. Mr. Weber has been the Chief Executive Officer of Newron Pharmaceuticals SpA since June 1, 201...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 11.8yrs | €510.00k | 0.11% € 136.2k | |
| Chief Financial Officer | 11.8yrs | no data | 0.013% € 16.7k | |
| Vice President of Operations | 1.8yrs | no data | no data | |
| Chief Medical Officer | 18.9yrs | €1.12m | 0.22% € 280.1k | |
| Vice President of Business Development | less than a year | no data | no data |
11.8yrs
Average Tenure
Experienced Management: NWRN's management team is seasoned and experienced (11.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 12.3yrs | €510.00k | 0.11% € 136.2k | |
| Independent Non-Executive Director | 15.8yrs | €78.00k | 0.064% € 80.3k | |
| Independent Non-Executive Chairman | 11yrs | €106.00k | 0.22% € 269.3k | |
| Non-Executive & Independent Director | 10.1yrs | €68.00k | no data | |
| Member of Scientific & Clinical Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific and Clinical Advisory Board | no data | no data | no data | |
| Member of Scientific & Clinical Advisory Board | no data | no data | no data | |
| Member of Scientific & Clinical Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Chairman of the Board of Statutory Auditors | 22.3yrs | €13.00k | no data |
12.3yrs
Average Tenure
62yo
Average Age
Experienced Board: NWRN's board of directors are seasoned and experienced ( 12.3 years average tenure).